Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Rhythm Pharmaceuticals (RYTM) Other Gross PP&E Adjustments (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Other Gross PP&E Adjustments for 10 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 240.12% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, up 240.12% year-over-year, with the annual reading at $3.3 million for FY2025, 240.12% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $3.3 million at Rhythm Pharmaceuticals, up from -$3.4 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $3.3 million in Q4 2025, with the low at -$9.3 million in Q3 2024.
  • Average Other Gross PP&E Adjustments over 5 years is -$3.0 million, with a median of -$3.2 million recorded in 2021.
  • The sharpest move saw Other Gross PP&E Adjustments soared 336.75% in 2023, then plummeted 748.28% in 2024.
  • Over 5 years, Other Gross PP&E Adjustments stood at $1.4 million in 2021, then crashed by 123.95% to -$332000.0 in 2022, then skyrocketed by 336.75% to $786000.0 in 2023, then crashed by 400.0% to -$2.4 million in 2024, then soared by 240.12% to $3.3 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $3.3 million, -$3.4 million, and -$3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.